Skip to content
Home
About Us
Science
Therapeutic Areas
Pipeline
Resources & Publications
For Patients
Patient Resources
Clinical Trials
Join Cullinan
News
Contact Us
Investors
Overview
Events & Presentations
SEC Filings
Stock Information
Corporate Governance
Investor FAQs
Email Alerts
Back
Home
About Us
Science
Therapeutic Areas
Pipeline
Resources & Publications
For Patients
Patient Resources
Clinical Trials
Join Cullinan
News
Contact Us
Investors
Overview
Events & Presentations
SEC Filings
Stock Information
Corporate Governance
Investor FAQs
Email Alerts
Home
About Us
Science
Therapeutic Areas
Pipeline
Resources & Publications
For Patients
Patient Resources
Clinical Trials
Join Cullinan
News
Contact Us
Investors
Overview
Events & Presentations
SEC Filings
Stock Information
Corporate Governance
Investor FAQs
Email Alerts
Back
Home
About Us
Science
Therapeutic Areas
Pipeline
Resources & Publications
For Patients
Patient Resources
Clinical Trials
Join Cullinan
News
Contact Us
Investors
Overview
Events & Presentations
SEC Filings
Stock Information
Corporate Governance
Investor FAQs
Email Alerts
Browse a selection of key resources and publications about our pipeline.
Filter Resources & Publications
Programs:
CLN-978
Velinotamig
Zipalertinib
CLN-049
Therapeutic Areas:
Autoimmune Diseases
Cancer
Resource Type:
Video
Fact sheet
Poster
Presentation
Publication
Development Stage:
Preclinical
Clinical
View results
View all
Multicenter Phase 1/2a trial of CLN-081 (TAS6417) in NSCLC Patients with EGFR Exon 20 Insertion Mutations (2019 WCLC)
1
2
3
4
